Eplerenone 50 mg Tab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Poznan University of Medical Sciences
Overview
Eplerenone 50 mg Tab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Eplerenone 50 mg Tab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Eplerenone 50 mg Tab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.